AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
DRUG-NAIVE PATIENTS WITH PARKINSONS-DISEASE IN HOEHN AND YAHR STAGE-IAND STAGE-II SHOW A BILATERAL DECREASE IN STRIATAL DOPAMINE TRANSPORTERS AS REVEALED BY [I-123] BETA-CIT SPECT
Authors: TISSINGH G BERGMANS P BOOIJ J WINOGRODZKA A VANROYEN EA STOOF JC WOLTERS EC
Citation: G. Tissingh et al., DRUG-NAIVE PATIENTS WITH PARKINSONS-DISEASE IN HOEHN AND YAHR STAGE-IAND STAGE-II SHOW A BILATERAL DECREASE IN STRIATAL DOPAMINE TRANSPORTERS AS REVEALED BY [I-123] BETA-CIT SPECT, Journal of neurology, 245(1), 1998, pp. 14-20
L-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SPECT IN HEALTHY CONTROLS AND EARLY-STAGE, DRUG-NAIVE PARKINSONS-DISEASE
Authors: TISSINGH G BOOIJ J BERGMANS P WINOGRODZKA A JANSSEN AGM VANROYEN EA STOOF JC WOLTERS EC
Citation: G. Tissingh et al., L-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SPECT IN HEALTHY CONTROLS AND EARLY-STAGE, DRUG-NAIVE PARKINSONS-DISEASE, The Journal of nuclear medicine, 39(7), 1998, pp. 1143-1148
IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-FP-CIT SPECT IN HEALTHY CONTROLS AND PATIENTS WITH PARKINSONS-DISEASE
Authors: BOOIJ J HABRAKEN JBA BERGMANS P TISSINGH G WINOGRODZKA A WOLTERS EC JANSSEN AGM STOOF JC VANROYEN EA
Citation: J. Booij et al., IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-FP-CIT SPECT IN HEALTHY CONTROLS AND PATIENTS WITH PARKINSONS-DISEASE, The Journal of nuclear medicine, 39(11), 1998, pp. 1879-1884
DEPRESSION IN PARKINSONS-DISEASE - THE IMPACT OF SYMPTOM OVERLAP ON PREVALENCE
Authors: HOOGENDIJK WJG SOMMER C TISSINGH G DEEG DJH WOLTERS EC
Citation: Wjg. Hoogendijk et al., DEPRESSION IN PARKINSONS-DISEASE - THE IMPACT OF SYMPTOM OVERLAP ON PREVALENCE, Psychosomatics, 39(5), 1998, pp. 416-421
OLANZAPINE IN THE TREATMENT OF DOPAMINOMIMETIC PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE - REPLY FROM THE AUTHORS
Authors: WOLTERS EC JANSEN ENH TUYNMANQUA HG BERGMANS PLM
Citation: Ec. Wolters et al., OLANZAPINE IN THE TREATMENT OF DOPAMINOMIMETIC PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE - REPLY FROM THE AUTHORS, Neurology, 50(4), 1998, pp. 1196-1196
[I-123] BETA-CIT SINGLE-PHOTON EMISSION TOMOGRAPHY IN PARKINSONS-DISEASE REVEALS A SMALLER DECLINE IN DOPAMINE TRANSPORTERS WITH AGE THAN IN CONTROLS
Authors: TISSINGH G BERGMANS P BOOIJ J WINOGRODZKA A STOOF JC WOLTERS EC VANROYEN EA
Citation: G. Tissingh et al., [I-123] BETA-CIT SINGLE-PHOTON EMISSION TOMOGRAPHY IN PARKINSONS-DISEASE REVEALS A SMALLER DECLINE IN DOPAMINE TRANSPORTERS WITH AGE THAN IN CONTROLS, European journal of nuclear medicine, 24(9), 1997, pp. 1171-1174
PRACTICAL BENEFIT OF [I-123] FP-CIT SPET IN THE DEMONSTRATION OF THE DOPAMINERGIC DEFICIT IN PARKINSONS-DISEASE
Authors: BOOIJ J TISSINGH G WINOGRODZKA A BOER GJ STOOF JC WOLTERS EC VANROYEN EA
Citation: J. Booij et al., PRACTICAL BENEFIT OF [I-123] FP-CIT SPET IN THE DEMONSTRATION OF THE DOPAMINERGIC DEFICIT IN PARKINSONS-DISEASE, European journal of nuclear medicine, 24(1), 1997, pp. 68-71
RCBF SPECT IN PARKINSONS-DISEASE PATIENTS WITH MENTAL DYSFUNCTION
Authors: BISSESSUR S TISSINGH G WOLTERS EC SCHELTENS P
Citation: S. Bissessur et al., RCBF SPECT IN PARKINSONS-DISEASE PATIENTS WITH MENTAL DYSFUNCTION, Journal of neural transmission. Supplementum, (50), 1997, pp. 25-30
IBZM-SPECT AND CIT-SPECT OF THE DOPAMINERGIC SYSTEM IN PARKINSONISM
Authors: TISSINGH G BOOIJ J WINOGRODZKA A VANROYEN EA WOLTERS EC
Citation: G. Tissingh et al., IBZM-SPECT AND CIT-SPECT OF THE DOPAMINERGIC SYSTEM IN PARKINSONISM, Journal of neural transmission. Supplementum, (50), 1997, pp. 31-37
NIGROSTRIATAL DOPAMINERGIC IMAGING WITH IODINE-123-BETA-CIT-FP SPECT AND FLUORINE-18-FDOPA/PET/
Authors: TISSINGH G BERGMANS P WINOGRODZKA A STOOF JC WOLTERS EC BOOIJ J VANROYEN EA
Citation: G. Tissingh et al., NIGROSTRIATAL DOPAMINERGIC IMAGING WITH IODINE-123-BETA-CIT-FP SPECT AND FLUORINE-18-FDOPA/PET/, The Journal of nuclear medicine, 38(8), 1997, pp. 1271-1272
[I-123] FP-CIT SPECT DISCRIMINATES BETWEEN GROUPS OF EARLY NONMEDICATED PATIENTS WITH PARKINSONS-DISEASE AND CONTROLS
Authors: BOOIJ J TISSINGH G BERGMANS P COSTA DC WINOGRODZKA A JANSSEN AGM WOLTERS EC STOOF JC VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT SPECT DISCRIMINATES BETWEEN GROUPS OF EARLY NONMEDICATED PATIENTS WITH PARKINSONS-DISEASE AND CONTROLS, The Journal of nuclear medicine, 38(5), 1997, pp. 518-518
[I-123] FP-CIT SPECT SHOWS A PRONOUNCED DECLINE OF STRIATAL DOPAMINE TRANSPORTER LABELING IN EARLY AND ADVANCED PARKINSONS-DISEASE
Authors: BOOIJ J TISSINGH G BOER GJ SPEELMAN JD STOOF JC JANSSEN AGM WOLTERS EC VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT SPECT SHOWS A PRONOUNCED DECLINE OF STRIATAL DOPAMINE TRANSPORTER LABELING IN EARLY AND ADVANCED PARKINSONS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 62(2), 1997, pp. 133-140
THE ROLE OF D-1 AND D-2 DOPAMINE-RECEPTORS IN MOTOR BEHAVIOR OF PATIENTS WITH PARKINSONS-DISEASE
Authors: WOLTERS EC
Citation: Ec. Wolters, THE ROLE OF D-1 AND D-2 DOPAMINE-RECEPTORS IN MOTOR BEHAVIOR OF PATIENTS WITH PARKINSONS-DISEASE, European journal of neurology, 3, 1996, pp. 19-24
DOPAMINERGIC SYSTEMS AND PARKINSONS-DISEASE - SOME LATEST DEVELOPMENTS IN PATHOGENETIC, DIAGNOSTIC AND PHARMACOTHERAPEUTIC INVESTIGATIONS
Authors: STOOF JC VERMEULEN RJ VANROYEN EA DRUKARCH B VOORN P WOLTERS EC GROENEWEGEN HJ
Citation: Jc. Stoof et al., DOPAMINERGIC SYSTEMS AND PARKINSONS-DISEASE - SOME LATEST DEVELOPMENTS IN PATHOGENETIC, DIAGNOSTIC AND PHARMACOTHERAPEUTIC INVESTIGATIONS, Neuroscience research communications, 18(3), 1996, pp. 133-142
INTERNATIONAL (NL-UK) DOUBLE-BLIND-STUDY OF SINEMET CR AND STANDARD SINEMET (25 100) IN 170 PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE/
Authors: WOLTERS EC TESSELAAR HJM BUSSEMAKER FEAM DAMMERS JWHH HAAS JA HORSTINK MWIM JANSEN ENH KORTEN JJ LAKKE JPWF DECOUL AAWO PEPERKAMP JPC ROOS RAC RUTGERS AWF TIJSSEN CC VANDERZWAN A VANLAAR T VANLEUSDEN JA VANROSSUM J VERBIEST HBC VERMEIJ AJ BAKHEIT J BATES D CAPILDEO R CHAND J KENNEDY P LEES A PARK D STURMAN S TURJANSKI N WILLIAMS A
Citation: Ec. Wolters et al., INTERNATIONAL (NL-UK) DOUBLE-BLIND-STUDY OF SINEMET CR AND STANDARD SINEMET (25 100) IN 170 PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE/, Journal of neurology, 243(3), 1996, pp. 235-240
[I-123] FP-CIT SPECT REVEALS MARKED DECLINE OF STRIATAL SIGNAL IN PARKINSONS-DISEASE MEASURABLE 3H POST-INJECTION
Authors: BOOIJ J COSTA DC TISSINGH G BOER GJ JANSSEN AGM SPEELMAN JD WOLTERS EC STOOF JC VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT SPECT REVEALS MARKED DECLINE OF STRIATAL SIGNAL IN PARKINSONS-DISEASE MEASURABLE 3H POST-INJECTION, The Journal of nuclear medicine, 37(5), 1996, pp. 525-525
OLANZAPINE IN THE TREATMENT OF DOPAMINOMIMETIC PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE
Authors: WOLTERS EC JANSEN ENH TUYNMANQUA HG BERGMANS PLM
Citation: Ec. Wolters et al., OLANZAPINE IN THE TREATMENT OF DOPAMINOMIMETIC PSYCHOSIS IN PATIENTS WITH PARKINSONS-DISEASE, Neurology, 47(4), 1996, pp. 1085-1087
MORPHINE AND NALTREXONE MODULATE D-2 BUT NOT D-1 RECEPTOR-INDUCED MOTOR BEHAVIOR IN MPTP-LESIONED MONKEYS
Authors: VERMEULEN RJ DRUKARCH B SAHADAT MCR GOOSEN C SCHOFFELMEER ANM WOLTERS EC STOOF JC
Citation: Rj. Vermeulen et al., MORPHINE AND NALTREXONE MODULATE D-2 BUT NOT D-1 RECEPTOR-INDUCED MOTOR BEHAVIOR IN MPTP-LESIONED MONKEYS, Psychopharmacology, 118(4), 1995, pp. 451-459
EFFECTS OF UNILATERAL 6-HYDROXYDOPAMINE LESIONS ON NEUROPEPTIDE IMMUNOREACTIVITY IN THE BASAL GANGLIA OF THE COMMON MARMOSET, CALLITHRIX-JACCHUS, A QUANTITATIVE IMMUNOHISTOCHEMICAL ANALYSIS
Authors: ROELING TAP DOCTER GJ VOORN P MELCHERS BPC WOLTERS EC GROENEWEGEN HJ
Citation: Tap. Roeling et al., EFFECTS OF UNILATERAL 6-HYDROXYDOPAMINE LESIONS ON NEUROPEPTIDE IMMUNOREACTIVITY IN THE BASAL GANGLIA OF THE COMMON MARMOSET, CALLITHRIX-JACCHUS, A QUANTITATIVE IMMUNOHISTOCHEMICAL ANALYSIS, Journal of chemical neuroanatomy, 9(3), 1995, pp. 155-164
CONCENTRATIONS OF AMYLOID-BETA PROTEIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE
Authors: VANGOOL WA KUIPER MA WALSTRA GJM WOLTERS EC BOLHUIS PA
Citation: Wa. Vangool et al., CONCENTRATIONS OF AMYLOID-BETA PROTEIN IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE, Annals of neurology, 37(2), 1995, pp. 277-279
HISTOPATHOLOGIC CORRELATES OF WHITE-MATTER CHANGES ON MRI IN ALZHEIMERS-DISEASE AND NORMAL AGING
Authors: SCHELTENS P BARKHOF F LEYS D WOLTERS EC RAVID R KAMPHORST W
Citation: P. Scheltens et al., HISTOPATHOLOGIC CORRELATES OF WHITE-MATTER CHANGES ON MRI IN ALZHEIMERS-DISEASE AND NORMAL AGING, Neurology, 45(5), 1995, pp. 883-888
DOPAMINE AGONISTS IN PARKINSONS-DISEASE
Authors: WOLTERS EC TISSINGH G BERGMANS PLM KUIPER MA
Citation: Ec. Wolters et al., DOPAMINE AGONISTS IN PARKINSONS-DISEASE, Neurology, 45(3), 1995, pp. 28-34
NO EVIDENCE FOR ABNORMALITIES IN KINETICS OF PLATELET MONOAMINE-OXIDASE IN ALZHEIMERS-DISEASE
Authors: KONINGS CH SCHELTENS P KUIPER MA WOLTERS EC
Citation: Ch. Konings et al., NO EVIDENCE FOR ABNORMALITIES IN KINETICS OF PLATELET MONOAMINE-OXIDASE IN ALZHEIMERS-DISEASE, Clinica chimica acta, 240(1), 1995, pp. 99-102
CHANGED TRANSFERRIN SIALYLATION IN PARKINSONS-DISEASE
Authors: VANKAMP GJ MULDER K KUIPER M WOLTERS EC
Citation: Gj. Vankamp et al., CHANGED TRANSFERRIN SIALYLATION IN PARKINSONS-DISEASE, Clinica chimica acta, 235(2), 1995, pp. 159-167
CSF ACETYLCHOLINESTERASE IN PARKINSON DISEASE - DECREASED ENZYME-ACTIVITY AND IMMUNOREACTIVITY IN DEMENTED PATIENTS
Authors: KONINGS CH KUIPER MA MULDER C CALLIAUW J WOLTERS EC
Citation: Ch. Konings et al., CSF ACETYLCHOLINESTERASE IN PARKINSON DISEASE - DECREASED ENZYME-ACTIVITY AND IMMUNOREACTIVITY IN DEMENTED PATIENTS, Clinica chimica acta, 235(1), 1995, pp. 101-105
Risultati: 1-25 | 26-45